These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19188142)

  • 21. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
    Jia Y; Yin Y; Duan F; Fu H; Hu M; Gao Y; Pan Z; Jiao X
    Int J Mol Med; 2012 Dec; 30(6):1335-42. PubMed ID: 23027427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen-specific vaccines for cancer treatment.
    Tagliamonte M; Petrizzo A; Tornesello ML; Buonaguro FM; Buonaguro L
    Hum Vaccin Immunother; 2014; 10(11):3332-46. PubMed ID: 25483639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing cancer vaccine efficacy via modulation of the tumor microenvironment.
    Disis ML
    Clin Cancer Res; 2009 Nov; 15(21):6476-8. PubMed ID: 19861446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of processing and presentation of the antigens of Listeria monocytogenes.
    Hiltbold EM; Ziegler HK
    Infect Agents Dis; 1993 Oct; 2(5):314-23. PubMed ID: 7513598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccine for cancer immunotherapy.
    Yang B; Jeang J; Yang A; Wu TC; Hung CF
    Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Listeria as a vaccine vector.
    Bruhn KW; Craft N; Miller JF
    Microbes Infect; 2007 Aug; 9(10):1226-35. PubMed ID: 17719258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective immunity induced by a LLO-deficient Listeria monocytogenes.
    Yin Y; Zhang C; Dong H; Niu Z; Pan Z; Huang J; Jiao X
    Microbiol Immunol; 2010 Apr; 54(4):175-83. PubMed ID: 20377746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in silico DNA vaccine against Listeria monocytogenes.
    Jahangiri A; Rasooli I; Gargari SL; Owlia P; Rahbar MR; Amani J; Khalili S
    Vaccine; 2011 Sep; 29(40):6948-58. PubMed ID: 21791233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenicity of Listeria monocytogenes isolates in immunocompromised mice in relation to listeriolysin production.
    Tabouret M; De Rycke J; Audurier A; Poutrel B
    J Med Microbiol; 1991 Jan; 34(1):13-8. PubMed ID: 1899271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer.
    Basu P; Mehta A; Jain M; Gupta S; Nagarkar RV; John S; Petit R
    Int J Gynecol Cancer; 2018 May; 28(4):764-772. PubMed ID: 29538258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of listeriolysin-O (LLO) in the T lymphocyte response to infection with Listeria monocytogenes. Identification of T cell epitopes of LLO.
    Safley SA; Cluff CW; Marshall NE; Ziegler HK
    J Immunol; 1991 May; 146(10):3604-16. PubMed ID: 1709197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination of mice with attenuated mutants of Listeria monocytogenes: requirement for induction of macrophage la expression.
    Gahan CG; Collins JK
    Microb Pathog; 1995 Jun; 18(6):417-22. PubMed ID: 8551944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes.
    Sirard JC; Fayolle C; de Chastellier C; Mock M; Leclerc C; Berche P
    J Immunol; 1997 Nov; 159(9):4435-43. PubMed ID: 9379042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine.
    Pan ZK; Weiskirch LM; Paterson Y
    Cancer Res; 1999 Oct; 59(20):5264-9. PubMed ID: 10537307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-specific T cell receptor antagonism by antigen-presenting cells treated with the hemolysin of Listeria monocytogenes: a novel type of immune escape.
    Darji A; Stockinger B; Wehland J; Chakraborty T; Weiss S
    Eur J Immunol; 1997 Jul; 27(7):1696-703. PubMed ID: 9247580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell (DC) vaccine.
    Kono M; Nakamura Y; Suda T; Uchijima M; Tsujimura K; Nagata T; Giermasz AS; Kalinski P; Nakamura H; Chida K
    Vaccine; 2012 Mar; 30(16):2633-9. PubMed ID: 22365841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Searching for the ideal cancer vaccine.
    Cancer Biol Ther; 2009 Jan; 8(2):104-5. PubMed ID: 19263513
    [No Abstract]   [Full Text] [Related]  

  • 39. An H2-T MHC class Ib molecule presents Listeria monocytogenes-derived antigen to immune CD8+ cytotoxic T cells.
    Bouwer HG; Lindahl KF; Baldridge JR; Wagner CR; Barry RA; Hinrichs DJ
    J Immunol; 1994 Jun; 152(11):5352-60. PubMed ID: 8189053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment.
    Wallecha A; Singh R; Malinina I
    J Immunother; 2013; 36(9):468-76. PubMed ID: 24145358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.